Literature DB >> 30227226

International high-risk clonal lineages of CTX-M-producing Escherichia coli F-ST648 in free-roaming cats, South America.

Miriam R Fernandes1, Fábio P Sellera2, Quézia Moura3, Vitor C Gaspar2, Louise Cerdeira1, Nilton Lincopan4.   

Abstract

The dissemination of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli belonging to high-virulent pandemic lineages has become a global problem with serious consequences for public health worldwide. In this regard, E. coli lineages belonging to the sequence type ST648, which are mostly associated with human infections, have begun to be reported in animals. In this study, we report the identification and genomic characterization of international CTX-M-producing E. coli ST648/F lineages in free-roaming cats from an urban slum, in Brazil. Moreover, we have performed a comparative genomic analysis of worldwide reported E. coli ST648 strains, highlighting an epidemiologic linkage between human and companion animals.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brazil; Companion animals; ESBL; Latin America; Pandemic clone; Pets

Mesh:

Substances:

Year:  2018        PMID: 30227226     DOI: 10.1016/j.meegid.2018.09.009

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

1.  ESBL/pAmpC-Producing Escherichia coli Causing Urinary Tract Infections in Non-Related Companion Animals and Humans.

Authors:  Adriana Belas; Cátia Marques; Juliana Menezes; Luís Telo da Gama; Patrícia Cavaco-Silva; Constança Pomba
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  Prevalence and Molecular Characterization of Fluoroquinolone-Resistant Escherichia coli in Healthy Children.

Authors:  Qiang Zhao; Yueyun Shen; Gang Chen; Yanping Luo; Shenghui Cui; Yaping Tian
Journal:  Front Cell Infect Microbiol       Date:  2021-12-13       Impact factor: 5.293

3.  WHO Critical Priority Escherichia coli as One Health Challenge for a Post-Pandemic Scenario: Genomic Surveillance and Analysis of Current Trends in Brazil.

Authors:  Bruna Fuga; Fábio P Sellera; Louise Cerdeira; Fernanda Esposito; Brenda Cardoso; Herrison Fontana; Quézia Moura; Adriana Cardenas-Arias; Elder Sano; Rosineide M Ribas; Albalúcia C Carvalho; Maria Cristina B Tognim; Marcia Maria C de Morais; Ana Judith P G Quaresma; Ângela Patrícia Santana; Joice N Reis; Marcelo Pilonetto; Eliana Carolina Vespero; Raquel R Bonelli; Aloysio M F Cerqueira; Thaís C M Sincero; Nilton Lincopan
Journal:  Microbiol Spectr       Date:  2022-03-02

4.  First Report of Extended-Spectrum β-Lactamase (blaCTX-M1) and Colistin Resistance Gene mcr-1 in E. coli of Lineage ST648 from Cockroaches in Tunisia.

Authors:  Sarrah Landolsi; Rachid Selmi; Linda Hadjadj; Asma Ben Haj Yahia; Kaouther Ben Romdhane; Lilia Messadi; Jean Marc Rolain
Journal:  Microbiol Spectr       Date:  2022-03-01

5.  World Health Organization critical priority Escherichia coli clone ST648 in magnificent frigatebird (Fregata magnificens) of an uninhabited insular environment.

Authors:  Ana Carolina Ewbank; Danny Fuentes-Castillo; Carlos Sacristán; Fernanda Esposito; Bruna Fuga; Brenda Cardoso; Silvia Neri Godoy; Roberta Ramblas Zamana; Marco Aurélio Gattamorta; José Luiz Catão-Dias; Nilton Lincopan
Journal:  Front Microbiol       Date:  2022-08-11       Impact factor: 6.064

Review 6.  Extended-Spectrum Beta-Lactamases Producing Escherichia coli in South America: A Systematic Review with a One Health Perspective.

Authors:  Carlos Bastidas-Caldes; Daniel Romero-Alvarez; Victor Valdez-Vélez; Roberto D Morales; Andrés Montalvo-Hernández; Cicero Gomes-Dias; Manuel Calvopiña
Journal:  Infect Drug Resist       Date:  2022-09-30       Impact factor: 4.177

7.  Diarrheal bacterial pathogens and multi-resistant enterobacteria in the Choqueyapu River in La Paz, Bolivia.

Authors:  Jessica Guzman-Otazo; Lucia Gonzales-Siles; Violeta Poma; Johan Bengtsson-Palme; Kaisa Thorell; Carl-Fredrik Flach; Volga Iñiguez; Åsa Sjöling
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.